Prevalence of Molecular Mechanisms of Resistance to Azole Antifungal Agents in <i>Candida albicans</i> Strains Displaying High-Level Fluconazole Resistance Isolated from Human Immunodeficiency Virus-Infected Patients
Sofía Perea(The University of Texas at San Antonio Health Science Center), Thomas F. Patterson(Radboud University Medical Center), Marcos Martı́nez(The University of Texas at San Antonio Health Science Center), Dominique Sanglard, David Calabrese(University Hospital of Lausanne), William R. Kirkpatrick(The University of Texas at San Antonio Health Science Center), Rebecca A. Santillán(The University of Texas at San Antonio Health Science Center), Robert K. McAtee(The University of Texas at San Antonio Health Science Center), José L. López-Ribot(Texas Center for Infectious Disease)
Cited by 471
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2016|2.8k
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
|Clinical Infectious Diseases|2008|2.7k